Review paper
Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies
Abstract
The ability to change the genetic information of immune cells is a powerful tool for basic and clinical settings. CRISPR/Cas9 gene editing technology by providing an efficient approach has accelerated immune cell therapy of cancers. Lymphoid cancers comprise a wide array of disease including lymphoma, multiple myeloma and lymphocytic leukemia. Here, we review therapeutic applications of the CRISPR/Cas9 technology for immune cell therapy of...
Paper Details
Title
Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies
Published Date
Oct 1, 2020
Journal
Volume
226
Pages
71 - 82
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History